{
    "2019-01-24": [
        [
            {
                "time": "2019-01-24",
                "original_text": "Cost on the rise: Congress to investigate Big Pharma",
                "features": {
                    "keywords": [
                        "cost",
                        "rise",
                        "Congress",
                        "investigate",
                        "Big Pharma"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "Skyrocketing health care costs key topic at Davos",
                "features": {
                    "keywords": [
                        "skyrocketing",
                        "health care",
                        "costs",
                        "Davos"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "Health Care Sector Update for 01/24/2019: URGN, BMY, TTNP, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "URGN",
                        "BMY",
                        "TTNP",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Grim Outlook",
                        "Big Pharma",
                        "Stocks"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "Analysts Forecast 12% Upside For The Holdings of IVW",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Forecast",
                        "12%",
                        "Upside",
                        "Holdings",
                        "IVW"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "JNJ or ABT: Which Company Returns Higher Shareholder Value?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "ABT",
                        "Shareholder Value"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Grim Outlook",
                        "Big Pharma",
                        "Stocks"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "What To Know Before Buying Johnson & Johnson (NYSE:JNJ) For Its Dividend",
                "features": {
                    "keywords": [
                        "Buying",
                        "Johnson & Johnson",
                        "Dividend"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-24",
                "original_text": "Alphabet ECG Feature OK'd by FDA, Healthcare Plans on Track",
                "features": {
                    "keywords": [
                        "Alphabet",
                        "ECG",
                        "Feature",
                        "FDA",
                        "Healthcare",
                        "Plans"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}